Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 11:38 am Purchase | 2021-12-31 | 13G | New Providence Acquisition Corp. II NPABU | OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 2,227,500 7.130% | 2,227,500 (New Position) | Filing History |
| 2022-02-14 11:34 am Purchase | 2021-12-31 | 13G | NewHold Investment Corp III NHIC | OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,732,500 7.110% | 1,732,500 (New Position) | Filing History |
| 2022-02-14 11:28 am Purchase | 2021-12-31 | 13G | Magellan Health, Inc. MGLN | OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,366,939 5.190% | 1,366,939 (New Position) | Filing History |
| 2022-02-14 11:17 am Purchase | 2021-12-31 | 13G | Heron Therapeutics, Inc. HRTX | OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 8,275,000 8.120% | 8,275,000 (New Position) | Filing History |
| 2022-02-14 11:12 am Purchase | 2021-12-31 | 13G | Home Plate Acquisition Corp. HPLT | OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,980,000 7.690% | 1,980,000 (New Position) | Filing History |
| 2022-02-14 11:05 am Sale | 2021-12-31 | 13G | GTY Technology Holdings Inc. GTYH | OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 758,000 1.320% | -4,655,674 (-86.00%) | Filing History |
| 2022-02-14 10:59 am Sale | 2021-12-31 | 13G | GreenSky, Inc. GSKY | OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 698,553 0.760% | -6,255,302 (-89.95%) | Filing History |
| 2022-02-14 10:52 am Purchase | 2021-12-31 | 13G | Gesher I Acquisition Corp. GIAC | OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,021,225 7.010% | 1,021,225 (New Position) | Filing History |
| 2022-02-14 10:46 am Purchase | 2021-12-31 | 13G | Far Peak Acquisition Corporation FPAC | OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 3,886,068 5.570% | 3,886,068 (New Position) | Filing History |
| 2022-02-14 10:41 am Unchanged | 2021-12-31 | 13G | Sharecare, Inc. SHCR | OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 0 0.000% | 0 (Unchanged) | Filing History |
| 2022-02-14 10:37 am Purchase | 2021-12-31 | 13G | Conyers Park III Acquisition Corp. CPAA | OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 3,205,991 7.180% | 3,205,991 (New Position) | Filing History |
| 2022-02-14 10:34 am Sale | 2021-12-31 | 13G | Amryt Pharma plc AMYT | OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 9,950,000 3.110% | -3,263,340 (-24.70%) | Filing History |
| 2022-02-14 10:29 am Unchanged | 2021-12-31 | 13G | Jasper Therapeutics, Inc. JSPR | OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 0 0.000% | 0 (Unchanged) | Filing History |
| 2022-02-14 10:26 am Purchase | 2021-12-31 | 13G | Alpha Healthcare Acquisition Corp. III ALPA | OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,485,000 7.510% | 1,485,000 (New Position) | Filing History |
| 2022-02-14 10:21 am Purchase | 2021-12-31 | 13G | AfterNext HealthTech Acquisition Corp. AFTR | OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,557,405 6.230% | 1,557,405 (New Position) | Filing History |
| 2022-02-14 10:16 am Unchanged | 2021-12-31 | 13G | Acorda Therapeutics, Inc. ACOR | OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 0 0.000% | 0 (Unchanged) | Filing History |
| 2022-02-14 10:09 am Purchase | 2021-12-31 | 13G | Evolv Technologies Holdings, Inc. EVLV | OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,547,311 1.090% | 1,547,311 (New Position) | Filing History |
| 2021-02-16 10:41 am Purchase | 2020-12-31 | 13G | Acorda Therapeutics, Inc. ACOR | OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 266,162 9.990% | 266,162 (New Position) | Filing History |
| 2021-02-16 10:39 am Purchase | 2020-12-31 | 13G | Teligent, Inc. TLGT | OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 2,000,001 8.400% | 2,000,001 (New Position) | Filing History |
| 2021-02-16 10:37 am Purchase | 2020-12-31 | 13G | Shift Technologies, Inc. SFT | OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 5,625 0.100% | 5,625 (New Position) | Filing History |